Isolation and characterisation of poliovirus mutants resistant to heating at 50°C for 30 min

Journal of Medical Virology

Volumn 74, Issue 3, 2004, Pages 484-491

  Shiomi, Hiroshi ^a   Urasawa, Tomoko ^a,d   Urasawa, Shozo ^a,e   Kobayashi, Nobumichi ^a   Abe, Shibobu ^b   Taniguchi, Koki ^a,c  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Japan Poliomyelitis Research Institute   (Japan)

^c FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d TENSHI COLLEGE   (Japan)

^e FUJI WOMEN'S UNIVERSITY   (Japan)

Author keywords

Mutant; Poliovirus; Sabin strain; Thermostability; Vaccine

Indexed keywords

ALANINE; AMINO ACID; NUCLEOTIDE; ORAL POLIOMYELITIS VACCINE; VALINE; VIRUS RNA;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIGENICITY; ARTICLE; ELECTRON MICROSCOPY; GENETIC STABILITY; HEATING; NONHUMAN; NUCLEOTIDE SEQUENCE; POLIOMYELITIS VIRUS; SINGLE NUCLEOTIDE POLYMORPHISM; THERMOSTABILITY; VIROGENESIS; VIRUS CHARACTERIZATION; VIRUS INACTIVATION; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS MORPHOLOGY; VIRUS MUTANT; VIRUS PARTICLE; VIRUS STRAIN;

AMINO ACID SUBSTITUTION; ANIMALS; CAPSID PROTEINS; CELL LINE; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; FREEZE DRYING; HEAT; MACACA FASCICULARIS; MICROSCOPY, ELECTRON; POINT MUTATION; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; RNA, VIRAL;

POLIOVIRUS;

EID: 4644305750     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20202     Document Type: Article

References (26)

1. Andries K, Rombaut B, Dewindt B, Boeye A. 1994. Discrepancy between infectivity and antigenicity stabilization of oral poliovirus vaccine by a capsid-binding compound. J Virol 68:3397-3400.
2. Bauer DJ, Selway JWT, Batchelor JF, Tisdale M, Caldwell IC, Young DAB. 1981. 4′,6-Dichloroflavan (BW683C), a new anti-rhinovirus compound. Nature 292:369-370.
3. Breindl M. 1971. The structure of heated poliovirus particles. J Gen Virol 11:147-156.
4. Couderc T, Delpeyroux F, Blay H, Blondel B. 1996. Mouse adaptation determinants of poliovirus type 1 enhance viral uncoating. J Virol 70:305-312.
5. Crainic R, Wu R, Otelea D, Georgescu MM, Delpeyroux F, Guillot S, Balanant J, Tardy-Panit M. 1996. The replacement of water with deuterium oxide significantly improves the thermal stability of the oral poliovirus vaccine. Dev Biol Stand 87:161-166.
6. Dimmock NJ. 1967. Differences between the thermal inactivation of picornaviruses at "high" and "low" temperatures. Virology 3:338-353.
7. Hull HF, Birmingham ME, Melgaard B, Lee JW. 1997. Progress toward global polio eradication. J Infect Dis 175:S4-S9.
8. Kirkegaard K. 1990. Mutations in VP1 of poliovirus specifically affect both encapsidation and release of viral RNA. J Virol 64: 195-206.
9. Mayer MM, Rapp HJ, Roizman B, Klein SW, Cowan KM, Lukens D, Schwerdt CE, Schaffer FL, Charney J. 1957. The purification of poliomyelitis virus as studied by complement fixation. J Immunol 78:435-455.
10. Melnick JL. 1992. Poliomyelitis: Eradication in sight. Epidemiol Infect 108:1-18.
11. Melnick JL, Wallis C. 1963. Effect of pH on thermal stabilization of oral poliovirus vaccine by magnesium chloride. Proc Soc Exp Biol Med 112:894-897.
12. Milstien JB, Lemon SM, Wright PF. 1997. Development of a more thermostable poliovirus vaccine. J Infect Dis 175:S47-S53.
13. Moscufo N, Chow M. 1992. Myristate-protein interactions in poliovirus: Interactions of VP4 threonine 28 contribute to the structural conformation of assembly intermediates and the stability of assembled virions. J Virol 66:6849-6857.
14. Mosser AG, Sgro JY, Rueckert RR. 1994. Distribution of drug resistance mutations in type 3 poliovirus identifies three regions involved in uncoating functions. J Virol 68:8193-8201.
15. Papaevangelou GJ, Youngner JS. 1961. Correlation between heat-resistance of polioviruses and other genetic markers. Proc Soc Exp Biol Med 108:505-507.
16. Rombaut B, Andries K, Boeye A. 1991. A comparison of WIN 51711 and R 78206 as stabilizers of poliovirus virions and procapsids. J Gen Virol 72:2153-2157.
17. Rombaut B, Verheyden B, Andries K, Boeye A. 1994. Thermal inactivation of oral polio vaccine: Contribution of RNA and protein inactivation. J Virol 68:6454-6457.
18. Rueckert RR. 1996. Picornaviridae: The viruses and their replication. In: Fields BN, Knipe DN, Howley PM, Chanock RM, Melnick JL, Monath TP, Roizman B, Straus SE, editors. Field's virology. Philadelphia: Lippincott-Raven. pp 609-654.
19. Shiomi H, Urasawa T, Urasawa S. 2003. Heat stability of the lyophilized Sabin poliovaccine. Jpn J Infect Dis 56:70-72.
20. Stanley NF, Dorman DC, Ponsford J, Larkin M. 1956. Isolation of heat-resistant variant of polio-virus. Nature 178:413-414.
21. Taniguchi K, Urasawa T, Urasawa S. 1983. Monoclonal antibodies reactive with different sites of N and H antigenic particles of poliovirus. J Gen Virol 64:2803-2808.
22. Toyoda H, Kohara M, Kataoka Y, Suganuma T, Omata T, Imura N, Nomoto A. 1984. The complete nucleotide sequences of all three poliovirus serotype genomes: Implication for the genetic relationship, gene function, and antigenic determinants. J Mol Biol 174: 561-585.
23. Urasawa S, Urasawa T, Kanamitsu M. 1976. Further studies of specificity of antibodies contained in antiserum against poliovirus. Jpn J Microbiol 20:11-16.
24. Verheyden B, Andries K, Rombaut B. 2001. Capsid and RNA stabilization of the oral polio vaccine. Vaccine 19:1899-1905.
25. Wallis C, Melnick JL. 1963. Thermosensitivity of poliovirus. J Bacteriol 86:499-504.
26. Youngner JS. 1957. Thermal inactivation studies with different strains of poliovirus. J Immunol 78:282-290.